Best CBD Oil for Sleep in 2026: 7 Top Picks Tested Against Third-Party Labs
This article contains affiliate links. We may earn a commission from qualifying purchases at no extra cost to you. Best...
Read moreCBD (cannabidiol) and CBN (cannabinol) are both cannabis cannabinoids, but they work differently. CBD is directly extracted from hemp and has broad therapeutic properties: anti-inflammatory, anxiolytic, and neuroprotective. CBN forms as CBD ages or through heat exposure. CBN has mild intoxicating properties (though far less than THC) and works through different cannabinoid receptor pathways. While CBD is non-intoxicating, CBN may cause mild drowsiness at high doses.
CBD supports sleep by reducing anxiety and racing thoughts that prevent sleep onset. Studies show CBD doses of 10-25mg taken 1-2 hours before bed improve sleep quality and duration. CBD doesn’t force sleep like sedatives but rather removes barriers to natural sleep. Consistent nightly use (2-4 weeks) produces better results than occasional dosing. CBD is non-habit-forming and carries minimal side effects compared to sleep medications.
Early research suggests CBN may be more sedating than CBD, making it potentially superior for sleep. Some studies indicate CBN enhances sleep depth and REM duration. However, human clinical trials on CBN are limited. User reports are promising: doses of 5-15mg CBN show strong sleep-promoting effects. CBN products are rarer and often more expensive than CBD. For best results, some users combine CBD (15mg) with CBN (10mg) at bedtime.
CBD for sleep: 10-25mg taken 30-60 minutes before bed. CBN for sleep: 5-15mg taken 30-45 minutes before bed (more potent). Combined approach: 15mg CBD + 10mg CBN for synergistic effect. Take with fat (milk, nut butter) for better absorption. Avoid use after 3 PM on days when you need to be alert. Give any protocol 2-3 weeks for sleep quality to improve.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more